Notify me when Jean-Pierre Sommadossi files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Common Stock, par value $0.001 | 10.1% | $26.5M | 8.88M | Jean-Pierre Sommadossi | Mar 31, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|